Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fraunhofer USA is a non-profit applied research organization and the US-based affiliate of the German Fraunhofer-Gesellschaft. The organization operates several research centers, most notably the Center for Molecular Biotechnology (CMB), which specializes in plant-based vaccine and therapeutic development. Utilizing its proprietary Launch platform, Fraunhofer USA enables the rapid, scalable production of recombinant proteins in Nicotiana benthamiana plants. Its work spans infectious diseases, including influenza, malaria, and anthrax, as well as oncology and autoimmune disorders. Fraunhofer USA provides contract research, development, and GMP manufacturing services to government agencies like DARPA and NIH, as well as private industry partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fraunhofer USA.